Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06484257

Comparison Between Myopia Versus Hypermetropia With Progressive Addition Lenses in Computer Users

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Superior University · Academic / Other
Sex
All
Age
40 Years – 55 Years
Healthy volunteers
Not accepted

Summary

This study examines how myopia (nearsightedness) and hyperopia (farsightedness) affect the use of progressive addition lenses (PALs) for computer users. PALs offer a range of vision correction within one lens, ideal for presbyopia (age-related near focusing difficulty). We'll compare visual comfort, eye strain, and user preference for PALs between myopic and hyperopic individuals while focusing on computer screens.

Detailed description

The research will also consider if general-purpose PALs differ from computer-specific PALs in these user groups, and how presbyopia progression might influence PAL effectiveness for each condition. This information can help eye doctors recommend the most suitable PAL design for computer users with myopia or hyperopia.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMyopiaParticipants in this arm would receive progressive addition lenses specifically designed to correct myopia. These lenses would typically have a prescription for correcting nearsightedness (myopia) in addition to any other vision corrections needed, such as astigmatism correction and presbyopia. The participants would wear these lenses while using computers according to the study protocol.
OTHERHypermetropiaParticipants in this arm would receive progressive addition lenses specifically designed to correct hypermetropia. These lenses would typically have a prescription for correcting farsightedness (hypermetropia) in addition to any other vision corrections needed, such as astigmatism correction and presbyopia. The participants would wear these lenses while using computers according to the study protocol.

Timeline

Start date
2023-11-01
Primary completion
2024-06-01
Completion
2024-10-30
First posted
2024-07-03
Last updated
2024-07-03

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06484257. Inclusion in this directory is not an endorsement.